Areas of Focus
- Microbial-host interaction mechanisms
- Development of novel diagnostic and therapeutic methods
- Protection and reconstruction of epithelial and endothelial physical barriers
Work Experience
- 2022/03-present: Assistant Professor/Associate Researcher/Doctoral Supervisor at Southern University of Science and Technology, School of Medicine, Department of Pharmacology
- 2018-2022: Associate Researcher/Doctoral Supervisor at Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
Academic Background & Achievements
- 2003-2016: Bachelor's and PhD in Biomedical Engineering from National University of Singapore
- Full scholarship from the Ministry of Education of Singapore
Publications
- SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation, Li Liang (corresponding author), 2021
- Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on Airway Organoid Screening System, Li Liang (corresponding author), 2021
- Do engineered nanomaterials affect immune responses by interacting with gut microbiota?, Li Liang (corresponding author), 2021
- SARS-CoV-2 Detected on Environmental Fomites for both Asymptomatic and Symptomatic COVID-19 Patients, Li Liang (co-first author), 2021
- The Time Sequences of Oral and Fecal Viral Shedding of Coronavirus Disease 2019 (COVID-19) Patients, Li Liang (corresponding author), 2020
- Harnessing Colloidal Self-Assembled Patterns (cSAPs) to Regulate Bacterial and Human Stem Cell Response at Biointerfaces In Vitro and In Vivo, Li Liang (corresponding author), 2021
- Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during influenza pneumonia, Li Liang (first author), 2015
- Antibody treatment against angiopoietin-like 4 (ANGPTL4) reduces pulmonary edema and injury in secondary pneumococcal pneumonia, Li Liang (first author, corresponding author), 2019
- Serum Creatinine as a Potential Biomarker for the Diagnosis of Tuberculous Pleural Effusion, Li Liang (corresponding author), 2020
- Comparative Transcriptomics Unravels Prodigiosin's Potential Cancer-Specific Activity Between Human Small Airway Epithelial Cells and Lung Adenocarcinoma Cells, Li Liang (corresponding author), 2018
- Lovastatin Treatment Mitigates the pro-Inflammatory Cytokine Response in Respiratory Syncytial Virus Infected Macrophage Cells, Li Liang (co-first author), 2013
- Cold-chain-free Storable Hydrogel for Infant-friendly Oral Delivery of Amoxicillin for the Treatment of Pneumococcal Pneumonia, Li Liang, 2017
- A Systems-Based Approach to Analyse the Host Response in Murine Lung Macrophages Challenged with Respiratory Syncytial Virus, Li Liang, 2013
- Increased Hydroxymethylglutaryl Coenzyme A Reductase Activity during Respiratory Syncytial Virus Infection Mediates Actin Dependent Inter-Cellular Virus Transmission, Li Liang, 2013
- Comparative Transcriptomic and Metagenomic Analyses of Influenza Virus-Infected Nasal Epithelial Cells From Multiple Individuals Reveal Specific Nasal-Initiated Signatures, Li Liang, 2018
- Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression, Li Liang, 2017
- Supercritical carbon dioxide extracted extracellular matrix material from adipose tissue, Li Liang, 2017
- Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress, Li Liang, 2017
Awards
- 2019: Shenzhen Overseas High-level Talent
- 2015: Gold Award at the 9th Singapore Biomedical Engineering Research Conference
- 2012: Young Researcher Award, Asia-Pacific Conference on Medical Virology (APCMV), Adelaide, Australia
- 2012: Gold Award at the 6th Singapore Biomedical Engineering Research Conference